• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    2.01 Up 0.01(0.50%) Feb 5, 3:41PM EST
    Prev Close:2.00
    Open:2.00
    Bid:N/A
    Ask:3.20 x 1000
    1y Target Est:12.80
    Beta:1.60454
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:2.00 - 2.04
    52wk Range:1.69 - 8.64
    Volume:17,390
    Avg Vol (3m):215,971
    Market Cap:14.03M
    P/E (ttm):N/A
    EPS (ttm):-2.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OPXAUp 0.50%14.03M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.86
    Quarterly EPS Est (Dec-15) :-0.50
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback